These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 20167600)

  • 1. Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6.
    Wang H; Mo P; Ren S; Yan C
    J Biol Chem; 2010 Apr; 285(17):13201-10. PubMed ID: 20167600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating transcription factor 3 mediates apoptotic functions through a p53-independent pathway in human papillomavirus 18 infected HeLa cells.
    Kooti A; Abuei H; Farhadi A; Behzad-Behbahani A; Zarrabi M
    Virus Genes; 2022 Apr; 58(2):88-97. PubMed ID: 35129760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1.
    Drews CM; Case S; Vande Pol SB
    PLoS Pathog; 2019 Apr; 15(4):e1007575. PubMed ID: 31002735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity.
    Fu L; Van Doorslaer K; Chen Z; Ristriani T; Masson M; Travé G; Burk RD
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers.
    Zhou Y; Wei Y; Zhu J; Wang Q; Bao L; Ma Y; Chen Y; Feng D; Zhang A; Sun J; Nallar SC; Shen K; Kalvakolanu DV; Xiao W; Ling B
    PLoS One; 2011; 6(7):e22065. PubMed ID: 21765936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression‑independent manner in HPV‑positive human cervical cancer‑derived cells.
    Clemente-Soto AF; Salas-Vidal E; Milan-Pacheco C; Sánchez-Carranza JN; Peralta-Zaragoza O; González-Maya L
    Mol Med Rep; 2019 Mar; 19(3):2097-2106. PubMed ID: 30664221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Felis catus papillomavirus type-2 E6 binds to E6AP, promotes E6AP/p53 binding and enhances p53 proteasomal degradation.
    Altamura G; Power K; Martano M; Degli Uberti B; Galiero G; De Luca G; Maiolino P; Borzacchiello G
    Sci Rep; 2018 Dec; 8(1):17529. PubMed ID: 30510267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of MicroRNAs That Stabilize p53 in Human Papillomavirus-Positive Cancer Cells.
    Martínez-Noël G; Szajner P; Kramer RE; Boyland KA; Sheikh A; Smith JA; Howley PM
    J Virol; 2022 Feb; 96(4):e0186521. PubMed ID: 34878887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of small molecule human papillomavirus E6 inhibitors.
    Malecka KA; Fera D; Schultz DC; Hodawadekar S; Reichman M; Donover PS; Murphy ME; Marmorstein R
    ACS Chem Biol; 2014 Jul; 9(7):1603-12. PubMed ID: 24854633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells.
    Talis AL; Huibregtse JM; Howley PM
    J Biol Chem; 1998 Mar; 273(11):6439-45. PubMed ID: 9497376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes.
    Mesplède T; Gagnon D; Bergeron-Labrecque F; Azar I; Sénéchal H; Coutlée F; Archambault J
    J Virol; 2012 Jan; 86(1):94-107. PubMed ID: 22013048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.
    Martinez-Zapien D; Ruiz FX; Poirson J; Mitschler A; Ramirez J; Forster A; Cousido-Siah A; Masson M; Vande Pol S; Podjarny A; Travé G; Zanier K
    Nature; 2016 Jan; 529(7587):541-5. PubMed ID: 26789255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.
    Sanduja S; Kaza V; Dixon DA
    Aging (Albany NY); 2009 Sep; 1(9):803-17. PubMed ID: 20157568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human papillomavirus E6 oncogene represses a cell adhesion pathway and disrupts focal adhesion through degradation of TAp63β upon transformation.
    Ben Khalifa Y; Teissier S; Tan MK; Phan QT; Daynac M; Wong WQ; Thierry F
    PLoS Pathog; 2011 Sep; 7(9):e1002256. PubMed ID: 21980285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16.
    Li W; Anderson RA
    Oncogene; 2014 Feb; 33(7):928-32. PubMed ID: 23416977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
    Drews CM; Brimer N; Vande Pol SB
    PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function.
    Cherry JJ; Rietz A; Malinkevich A; Liu Y; Xie M; Bartolowits M; Davisson VJ; Baleja JD; Androphy EJ
    PLoS One; 2013; 8(12):e84506. PubMed ID: 24376816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of TP53 in Cervical carcinogenesis.
    Tommasino M; Accardi R; Caldeira S; Dong W; Malanchi I; Smet A; Zehbe I
    Hum Mutat; 2003 Mar; 21(3):307-12. PubMed ID: 12619117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells.
    Shamanna RA; Hoque M; Pe'ery T; Mathews MB
    Oncogene; 2013 Oct; 32(43):5176-85. PubMed ID: 23208500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.